Novaquest Capital Management is a North Carolina-based venture capital firm that makes late-stage investments in clinical and biopharmaceutical programs. Its stated goal is to meet the structural, accounting, and governance needs of its portfolio companies. As of January 2020, it has 16 companies in its portfolio and has had 18 exits. Between 2013 and 2019, Novaquest Capital Management has raised funds, ranging in amounts between $35 million and $892.2 million. In 2018, the firm acquired two organizations, both of which are pharmaceutical entities.
Roivant Sciences is a pharmaceutical company founded by Vivek Ramaswarmy. It focuses on the discovery and development of late-stage drug candidates.
Founder, Partner, and COO
Founder, Managing Partner, and CIO
NovaQuest Capital Closes $275 Million in Its Dedicated Private Equity Fund
November 20, 2019